Melissa Vyfhuis

Dr. Melissa Vyfhuis

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Advances in Radiation Oncology
Verified
Journal Article
Open access
CHChristopher P. Haskins
Christopher P. Haskins
CCColin E. Champ
Colin E. Champ
RMRobert Miller
Robert Miller
MVMelissa Vyfhuis
Melissa Vyfhuis
Poor nutrition is highly implicated in the pathogenesis of cancer and affects the survival of patients during and after completion of definitive therapies. Mechanistic evidence accumulated over the last century now firmly places dysregulated cellular energetics within the emerging hallmarks of cancer. Nutritional intervention studies often aim to either enhance treatment effect or treat nutritional deficiencies that portend poor prognoses. Patients living within food priority areas have a high risk of nutritional need and are more likely to develop comorbidities, including diabetes, hypertension, renal disease, and cardiovascular risk factors. Unfortunately, there is currently a paucity of data analyzing the impact of food priority areas on cancer outcomes. Therefore, we performed a review of the literature focusing on the molecular and clinical interplay of cancer and nutrition, the importance of clinical trials in elucidating how to intervene in this setting and the significance of including citizens who live in food priority areas in these future prospective studies. Given the importance of nutrition as an emerging hallmark of cancer, further research must be aimed at directing the optimal nutrition strategy throughout oncologic treatments, including the supplementation of nutritious foods to those that are otherwise unable to attain them

30 March 2021 in The Oncologist
Verified
Journal Article
Open access
PDF file
MVMelissa Vyfhuis
Melissa Vyfhuis
ISIkumi Suzuki
Ikumi Suzuki
SBSoren M. Bentzen
Soren M. Bentzen
KCKevin J. Cullen
Kevin J. Cullen
Olga GoloubevaOlga Goloubeva
Olga Goloubeva
Background In head and neck squamous cell carcinoma (HNSCC), black patients continue to have worse survival when compared to white patients. The cause of this disparity is multifaceted and cannot be explained by one etiology alone. To investigate this disparity, we utilized the Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database to examine adherence to guideline concordant care (GCC) as defined by the National Comprehensive Cancer Network (NCCN). Patients and Methods In this retrospective study, Medicare beneficiaries diagnosed with non‐metastatic HNSCC as their first cancer between 1992 and 2011, and a random sample of Medicare controls matched to cases (2:1) diagnosed between 2004 and 2011 (N=16378), were included in this analysis. Results Black patients were less likely to receive GCC in advanced stage oropharyngeal (66%vs.74%;p=0.007) and oral cavity (56%vs.71%;p=0.002) SCC. On multivariate analysis, black patients demonstrated an increased risk of death in advanced oropharyngeal (p<0.001), oral cavity (p=0.01), and hypopharyngeal (p=0.01) SCC. Conclusion Black patients did not consistently receive GCC across HNSCC subsites, contributing to the poorer outcomes seen when compared to white patients. Future research should focus on elucidating the mechanisms behind the non‐GCC given to black HNSCC patients and other factors that may contribute to this disparity such as tumor biology. Implications for Practice Black patients with head and neck cancer (HNC) continue to have worse survival than white patients. We examined if the racial disparity in survival from curable HNC is affected by adherence to guideline‐concordant care (GCC). We discovered that black patients were less likely to receive appropriate treatment in certain HNCs. Although adherence to proper therapy was associated with improved survival in HNC patients, the difference in survival, where black patients had inferior outcomes, remained. This analysis uncovered a major contributor to the disparity seen in HNC patients. As such, cancer centers serving a predominantly black HNC population, can design specific clinical interventions to ensure GCC for all patients, potentially improving outcomes for everyone.

1 January 2019 in Clinical Lung Cancer
Verified
Journal Article
Closed access
SRStephanie R. Rice
Stephanie R. Rice
JMJason K. Molitoris
Jason K. Molitoris
MVMelissa Vyfhuis
Melissa Vyfhuis
MEMartin J. Edelman
Martin J. Edelman
WBWhitney M. Burrows
Whitney M. Burrows
PMPranshu Mohindra
Pranshu Mohindra

1 July 2019 in Clinical Lung Cancer
Verified
Journal Article
Closed access
MVMelissa Vyfhuis
Melissa Vyfhuis
SBSøren M. Bentzen
Søren M. Bentzen
JMJason K. Molitoris
Jason K. Molitoris
TDTejan Diwanji
Tejan Diwanji
SBShahed Badiyan
Shahed Badiyan
PMPranshu Mohindra
Pranshu Mohindra

29 April 2022 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
DKDahlia Kronfli
Dahlia Kronfli
BSBansi Savla
Bansi Savla
ALAkilah Lievers
Akilah Lievers
KBKaysee Baker
Kaysee Baker
CECaitlin Eggleston
Caitlin Eggleston
MVMelissa Vyfhuis
Melissa Vyfhuis

28 September 2024 in Nutrition and Cancer
Verified
Journal Article
Closed access
AOAlexie Oppermann
Alexie Oppermann
SJShalet James
Shalet James
MMMackenzie M. Minotti
Mackenzie M. Minotti
KSKaitlin M. Schotz
Kaitlin M. Schotz
MFMartha E. Francis
Martha E. Francis
AKAmber S. Kleckner
Amber S. Kleckner
Radiotherapy is a common cancer treatment, and concurrent nutritional interventions can maintain nutritional status and improve clinical and supportive care outcomes. However, optimal nutritional interventions during radiotherapy are not firmly established. Herein, we assessed the feasibility, safety, and efficacy of dietary counseling interventions without oral nutrition supplements on health outcomes in adults receiving radiotherapy for cancer in a systematic review. Prospective clinical trials that implemented nutritional counseling interventions during radiotherapy were identified from four databases from inception through December 2023. Feasibility, safety, and efficacy were extracted from 32 articles that described 23 randomized and 4 non-randomized clinical trials. The interventions included individualized nutritional counseling (n = 14 articles), nutritional counseling plus exercise (n = 4), and nutritional counseling focused on increasing or reducing intake of specific nutrients (n = 9). Trials targeted head and neck (n = 12), pelvic cancers (n = 14), and/or breast (n = 5) cancers. Control groups had variable designs and included general nutrition education and intervention as needed. Studies recruited 120 ± 104 participants (range 26-468). Interventions tended to be feasible regarding retention and attendance at sessions, though feasibility metrics varied among different interventions. Most interventions were safe with no studies reporting adverse events attributable to dietary intervention. Individualized dietary counseling interventions tended to lead to between-group differences favoring the intervention group in regard to improved nutritional status, maintenance or attenuation of loss of body mass, improved quality of life, and reduced radiation-induced toxicities. Diets that encouraged/discouraged specific nutrients tended to recruit patients receiving radiation to the pelvic area and resulted in positive or neutral effects on gastrointestinal symptoms. In conclusion, nutritional interventions appear to be feasible, safe, and effective during radiotherapy for various symptom outcomes.